In November 2025, Parkinson’s disease stood out as one of the most frequently mentioned conditions examined by UK Parliamentarians and was mentioned nearly three times more often in November than its usual monthly average.
The UK Government announced on 1 December 2025 a landmark deal that is expected to benefit NHS patients by expanding access to vital medicines, strengthening the UK’s pharmaceutical supply chain, and attracting new investment into the country’s life sciences sector.
The MHRA published on 2 November 2025, a Policy Paper outlining the Agency’s intentions to improve regulatory pathways for rare disease therapies to be tested, manufactured and approved in the UK.
The NHS announced on 17 October 2025 that it would roll out a new long-acting injection to prevent HIV, as part of its ambition to become the first country in the world to end HIV transmissions by 2030.
The Government has appointed industry expert Steve Bates OBE as the new Executive Chair for the Office for Life Sciences. In his new role announced on 22 July 2025, Bates will act as an ambassador both domestically and internationally for the UK life sciences sector.
The UK Government unveiled its new Life Sciences Sector Plan on 16 July 2025, designed as a central pillar of its broader Industrial Strategy.
